Akvilė Rudaitytė received a BSc degree in biochemistry and molecular biology from the University College Dublin, Ireland, in 2017. Recently, she graduated with the MSc degree in medicinal chemistry by completing the joint master study programme at Kaunas University of Technology and Lithuanian University of Health Sciences in 2020. Her master thesis focused on using immune cell-derived extracellular vesicles as a drug delivery system to treat glioblastoma. Her research was presented at the 12th international Lithuanian Neuroscience Association conference, where she received the "Best Poster in Molecular Neuroscience" award. She completed an Erasmus internship in medical biotechnology at the University of Eastern Piedmont, Italy. Her main interests are cancer biology, immunotherapy, biotechnology, targeted therapy. She has a membership to the Lithuanian Association of Stem Cells Researchers.
Akvilė Rudaitytė received a BSc degree in biochemistry and molecular biology from the University College Dublin, Ireland, in 2017. Recently, she graduated with the MSc degree in medicinal chemistry by completing the joint master study programme at Kaunas University of Technology and Lithuanian University of Health Sciences in 2020. Her master thesis focused on using immune cell-derived extracellular vesicles as a drug delivery system to treat glioblastoma. Her research was presented at the 12th international Lithuanian Neuroscience Association conference, where she received the "Best Poster in Molecular Neuroscience" award. She completed an Erasmus internship in medical biotechnology at the University of Eastern Piedmont, Italy. Her main interests are cancer biology, immunotherapy, biotechnology, targeted therapy. She has a membership to the Lithuanian Association of Stem Cells Researchers.